Male Breast Cancer

Papillary carcinoma breast in male patient - A rare presentation

Dhruv Nayan Kundra, Anju Gupta, Rohit Agarwal, Surendra Vashisht, Pankaj Sareen


Introduction - Male breast carcinoma is rare, accounting for 1% of all malignancies in men and around 1% of all cases of breast carcinoma. Intracystic papillary carcinoma accounts for 0.5–1% of all breast cancers. It generally has good prognosis in women with almost 100% reported 10 year survival rate.Similar data for male patients is not available as the disease is extremely rare.

Presentation of Case - A 52 year-old male patient presented with a swelling in his left breast. Swelling had gradually increased in size. On examination, a well-circumscribed swelling was palpable in retro aerolar region with nipple retraction. Mass was not fixed to underlying pectoralis muscle.A large mobile axillary lymph node was palpable. Fine needle aspiration was done, which reported “atypical ductal hyperplasia”. A core biopsy was done which displayed features of intracystic papillary carcinoma. A left modified radical mastectomy was carried out with axillary dissection. The biopsy report of the specimen confirmed the diagnosis of intracystic papillary carcinoma, tumor deposits were seen in lymph nodes. Adjuvant chemotherapy was given postoperatively. Patient recovered well.

Conclusion - Intracystic papillary carcinoma is a rare malignancy of breast .It carries an excellent prognosis with upto 100% ten years survival rates reported in females.

Surgery with chemotherapy has remained mainstay of treatment but due to rarity of the male breast cancer as such and Intracystic papillary carcinoma in particular, there are no clear guidelines for its management. Further analysis of this disease is needed for its better understanding and management.



Intracystic papillary carcinoma

Full Text:



Fentiman IS, Fourquet A, Hortobagyi GN: Male breast cancer. Lancet 2006,367:595-604.

Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M,Galimberti V, Luini A, Orecchia R, Viale G, Goldhrisch A, Veronesi U: Male breast cancer: a special therapeutic problem. Anything new? (Review).Int J Oncol 2004, 24:663-670.

Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN: Breast carcinoma in men: a population-based study. Cancer 2004, 101:51-57.

Weiss JR, Moysich KB, Swede H. Epidemiology of breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:20-6.

Solorzano CC, Middleton LP, Hunt KK, Mirza N, Meric F, Kuerer HM,Ross MI, Ames FC, Feig BW, Pollock RE, Singletary SE, Babiera G:Treatment and outcome of patients with intracystic papillary

carcinoma of the breast. Am J Surg 2002, 184:364-368.

Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ:

Intracystic papillary carcinomas of the breast: a reevaluation

using a panel of myoepithelial cell markers. Am J Surg Pathol

, 30:1002-1007.

Lefkowitz M, Lefkowitz W, Wargotz ES: Intraductal (intracystic)

papillary carcinoma of the breast and its variants: a clinicopathological

study of 77 cases. Hum Pathol 1994, 25:802-809.

Levine PH, Waisman J, Yang GC: Aspiration cytology of cystic

carcinoma of the breast. Diagn Cytopathol 2003, 28:39-44.

Grabowski J, Salzstein SL, Sadler GR, Blair S: Intracystic papillary

carcinoma: a review of 917 cases. Cancer 2008, 113:916-920.

Blaumeiser B, Tjalma WA, Verslegers I, De Schepper AM, Buytaert P:Invasive papillary carcinoma of the male breast. Eur Radiol

, 12:2207-2210.

Fayanju OM, Ritter J, Gillanders WE, Eberlein TJ, Dietz JR, Aft R, Margenthaler JA: Therapeutic management of intracystic papillary

carcinoma of the breast: the roles of radiation and endocrine

therapy. Am J Surg 2007, 194:497-500.


  • There are currently no refbacks.

AJCC-REP (ISSN 2572-5742)Copyright © 2012-2021. All rights reserved. Published by Ivy Union Publishing, 3204 Valley Rush Dr, Apex, North Carolina 27502, United States